Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women
Clinical trial NCT03033836 · COMPLETED
Trial details
- NCT number
- NCT03033836
- Sponsor
- Fundación Huésped
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2019-06-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.